CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Source BioScience PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Source BioScience PLC
1 Orchard Place
Nottingham Business Park
Phone: +44 1159739012p:+44 1159739012 Nottingham, NG8 6PX  United Kingdom Ticker: SBSSBS
On 9/13/2016, Sherwood Holdings Limited acquired Source BioScience PLC.
This company is no longer actively traded on any major stock exchange.
Business Summary
Source BioScience PLC is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201512/31/2015Yes---Yes

Industries
SIC Code Description
8071 Medical laboratories
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Laurie A.Turnbull 65 1/1/2010 11/23/2006
Chief Executive Officer, Company Secretary, Executive Director Nick W.Ash 45 1/1/2010 8/31/2006
Chief Operating Officer, Executive Director Nick I.Leaves 47 1/1/2010 6/27/2008
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Source Bioscience Healthcare Ltd. Unit E1b, John Boyd Dunlop Drive Rochdale United Kingdom

Business Names
Business Name
imaGenes GmbH
Inverclyde Biologicals Ltd
Medical Solutions plc
SBS
Select Pharma Laboratories
Vindon Scientific Ltd

General Information
Number of Employees: 194 (As of 12/31/2015)
Outstanding Shares: 360,126,216 (As of 9/14/2016)
Shareholders: 3,586
Stock Exchange: LON
Fax Number: +44 1159739021


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023